CELC•globenewswire•
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026
Summary
MINNEAPOLIS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Guggenheim Emerging Outlook: Biotech Summit 2026 to be held in New York, New York on February 11-12, 2026.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 4, 2026 by globenewswire